Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pasithea Therapeutics Corp.

1.74
+0.00990.57%
Volume:68.23K
Turnover:119.77K
Market Cap:4.71M
PE:-0.14
High:1.80
Open:1.72
Low:1.55
Close:1.73
Loading ...
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 20, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 12, 2022

Major Issues Report

8-K - Current report
Sep 21, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 06, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 29, 2022

Major Issues Report

8-K/A [Amend] - Current report
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 29, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 27, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 27, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jun 24, 2022

Major Issues Report

8-K - Current report
Jun 24, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jun 22, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 10, 2022

Major Issues Report

8-K - Current report